1910 Genetics is a biotechnology company that is focused on developing gene therapies for rare genetic diseases. The company's mission is to use cutting-edge gene editing technology to cure genetic diseases that have no cure. 1910 Genetics is developing a pipeline of gene therapies that target a range of genetic diseases, including sickle cell anemia, cystic fibrosis, and Huntington's disease. The company's gene editing technology is based on the CRISPR-Cas9 system, which allows for precise and efficient editing of genes. 1910 Genetics was founded in 2019 and is headquartered in Menlo Park, California.